PE20.01 The Impact of Progestin-based Contraceptive Initiation on the Cervicovaginal Proteome in participants from the ECHO trialE-posterMicrobiome & STI: impact on prevention
PE20.02 The effect of HPV-associated anal dysplasia on HIV susceptibility in men who have sex with menE-posterMicrobiome & STI: impact on prevention
PE20.03 Mucosal responses to HIV-1 co-infection with an emerging pathogen, Zika virusE-posterMucosal immunity
PE20.04 The impact of TGF-β on the genital immune environment associated with HIV risk in young womenE-posterMucosal immunity
PE20.05 Impact of gender affirmation surgery and exogenous hormones on mucosal immune responses and risk of HIV transmission in transgender womenE-posterMucosal immunity
PE20.06 Acute sexual violence exposure dysregulates HIV associated cervical immune biomarkers in womenE-posterMucosal immunity
PE20.07 Effects of continued Progestin-based contraceptive usage in the adolescent genital tract: implications for HIV acquisitionE-posterMucosal immunity
PE20.08 The impact of human immunodeficiency virus-1 viral replicative capacity on infection of human cervical and rectal tissue explants ex vivoE-posterMucosal immunity
PE21.01 gp120-mediated CD4+ T cell activation is inhibited by non-neutralizing V2 loop antibodiesE-posterNovel vaccine and other prevention approaches
PE21.02 CD40-targeted vaccine increases magnitude of HIV-Env specific responsesE-posterNovel vaccine and other prevention approaches
seek-warrow-warrow-eseek-e391 - 400 of 444 items